Aitia
SF 7.2Causal AI and disease digital twins
Causal AI and disease digital twins
AI protein design for wet labs
Quick decision guide
Overview
Aitia is an AI drug discovery company for pharma and research partners, using causal AI and disease digital twins to identify drug targets and biomarkers.
Aitia is best evaluated through a focused pilot that tests one workflow, data requirements, and collaboration needs before broader commitment.
Cradle is an AI protein engineering platform for protein engineering and biotech teams, supporting the design and optimization of proteins for research programs.
Cradle is best assessed as an accessible protein design layer whose fit depends on wet-lab integration, in-house expertise, and research objectives.
Side-by-side
OVERLAP
Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.
Shared capabilities
Shared workflows
Feature check
The trade-offs
Catalog data lists these trade-offs for both tools.
Final verdict
Current catalog data shows meaningful overlap between Aitia and Cradle. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.
Aitia and Cradle share 8 catalog signals, so the decision should focus on fit rather than broad capability alone.
Aitia has 4 visible decision signals and Cradle has 4.
Cradle has the higher SoftFinders Score in the current catalog data.